List of insiders holdings for Sensei Biotherapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
H&S INVESTMENTS I LP H&S VENTURES LLC SCHULMAN MICHAEL SAMUELI HENRY SAMUELI SUSAN 10% Owner | 2022-02-14 15:01:52 | 4,441,624 0 | 4,441,624 | Form 13G |
Celebi John PRESIDENT AND CEO | 2024-02-16 18:28:57 | 586,309 0 | 586,309 | Form 4 |
Colgan Erin CHIEF FINANCIAL OFFICER | 2024-02-16 18:25:13 | 286,590 0 | 286,590 | Form 4 |
van der Horst Edward CHIEF SCIENTIFIC OFFICER | 2024-02-16 18:37:03 | 271,172 0 | 271,172 | Form 4 |
Krebs Stephanie Chief Business Officer | 2023-11-02 16:53:00 | 125,000 0 | 125,000 | Form 4 |
Pierce Robert Hamilton Chief R&D Officer | 2022-09-01 16:57:33 | 94,463 0 | 94,463 | Form 4/A |
Hoey Anupama Chief Business Officer | 2021-02-05 16:40:08 | 83,333 0 | 83,333 | Form 4 |
Craver Josiah Principal Financial Officer | 2024-09-26 16:36:21 | 80,000 0 | 80,000 | Form 3 |
Fjaellskog Marie-Louise Chief Medical Officer | 2021-02-05 16:39:18 | 79,166 0 | 79,166 | Form 4 |
Gallagher Patrick Stephen Chief Business Officer | 2023-09-11 17:34:32 | 34,130 0 | 34,130 | Form 4 |
Broder Samuel Director | 2023-07-12 17:00:38 | 23,482 0 | 23,482 | Form 4 |
Vojta Deneen Director | 2024-06-13 17:01:12 | 19,000 0 | 19,000 | Form 4 |
RICKS THOMAS G Director | 2024-06-13 17:03:30 | 19,000 0 | 19,000 | Form 4 |
RINGO WILLIAM R Director | 2024-06-13 17:04:48 | 19,000 0 | 19,000 | Form 4 |
Humer Kristian Director | 2024-06-13 17:06:05 | 19,000 0 | 19,000 | Form 4 |
English Jessie Director | 2024-06-13 17:07:18 | 19,000 0 | 19,000 | Form 4 |
Holmen Bob Director | 2024-06-13 17:08:22 | 19,000 0 | 19,000 | Form 4 |
Peyer James Director 10% Owner | 2024-06-13 17:10:20 | 0 19,000 | 19,000 | Form 4 |
Cambrian BioPharma Inc 10% Owner | 2024-06-13 17:11:53 | 19,000 0 | 19,000 | Form 4 |
Apeiron Investment Group Ltd. Angermayer Christian Presight Sensei Co-Invest Fund L.P. Presight Co-Invest Management L.L.C. 10% Owner | 2023-06-02 17:03:18 | 0 0 | 0 | Form 4 |
Gaiero David G Principal Financial Officer | 2024-05-16 16:55:09 | 0 0 | 0 | Form 3 |